Literature DB >> 7948309

Low doses of rHuEPO administered to adult patients with thalassemia intermedia.

F Dore, E Gaviano, S Bonfigli, S Pardini, P Pistidda, L Guiso, M Longinotti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7948309     DOI： 10.1007/bf02215956

Source DB:  PubMed          Journal:  Ann Hematol        ISSN： 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  5 in total

Review 1.  The molecular mechanism of erythropoietin action.

Authors:  M J Koury; M C Bondurant
Journal:  Eur J Biochem       Date:  1992-12-15

2.  Administration of erythropoietin to patients with beta-thalassemia intermedia: a preliminary trial.

Authors:  E A Rachmilewitz; A Goldfarb; G Dover
Journal:  Blood       Date:  1991-08-15       Impact factor: 22.113

3.  Serum immunoreactive erythropoietin level: a new parameter for monitoring transfusion management of thalassaemia.

Authors:  M André; P Bergmann; A Ferster; M Toppet; P Fondu
Journal:  Nouv Rev Fr Hematol       Date:  1991

4.  Serum erythropoietin levels in thalassemia intermedia.

Authors:  F Dore; S Bonfigli; E Gaviano; S Pardini; P Cianciulli; G Papa; M Longinotti
Journal:  Ann Hematol       Date:  1993-10       Impact factor: 3.673

5.  Trial of recombinant human erythropoietin: three patients with thalassemia intermedia.

Authors:  N F Olivieri; M H Freedman; S P Perrine; G J Dover; B Sheridan; D L Essentine; R L Nagel
Journal:  Blood       Date:  1992-12-15       Impact factor: 22.113
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.